Searched for: in-biosketch:true
person:ecm367
Does Inflammation Mediate the Association Between Obesity and Insulin Resistance?
Adabimohazab, Razieh; Garfinkel, Amanda; Milam, Emily C; Frosch, Olivia; Mangone, Alexander; Convit, Antonio
In adult obesity, low-grade systemic inflammation is considered an important step in the pathogenesis of insulin resistance (IR). The association between obesity and inflammation is less well established in adolescents. Here, we ascertain the importance of inflammation in IR among obese adolescents by utilizing either random forest (RF) classification or mediation analysis approaches. The inflammation balance score, composed of eight pro- and anti-inflammatory makers, as well as most of the individual inflammatory markers differed significantly between lean and overweight/obese. In contrast, adiponectin was the only individual marker selected as a predictor of IR by RF, and the balance score only revealed a medium-to-low importance score. Neither adiponectin nor the inflammation balance score was found to mediate the relationship between obesity and IR. These findings do not support the premise that low-grade systemic inflammation is a key for the expression of IR in the human. Prospective longitudinal studies should confirm these findings.
PMCID:4884488
PMID: 26956471
ISSN: 1573-2576
CID: 2024292
Well-Demarcated, Scaly Plaques
Milam, Emily C; Meehan, Shane A; Ramachandran, Sarika
PMID: 26836734
ISSN: 1538-3598
CID: 1931992
The use of oral antibiotics before isotretinoin therapy in patients with acne
Nagler, Arielle R; Milam, Emily C; Orlow, Seth J
BACKGROUND: Systemic antibiotics are used widely to treat moderate to severe acne, but increasing antibiotic resistance makes appropriate use a priority. OBJECTIVE: We sought to determine the duration of systemic antibiotic use in patients with inflammatory/nodulocystic acne who eventually required isotretinoin. METHODS: We performed a retrospective, single-site chart review of patients with acne diagnostic codes evaluated January 1, 2005 to December 31, 2014, at a dermatology practice in an academic medical center. Included patients were prescribed isotretinoin during the study period and received 30 days or more of antibiotics. RESULTS: The average duration of antibiotic use was 331.3 days. In all, 21 patients (15.3%) were prescribed antibiotics for 3 months or less, 88 patients (64.2%) for 6 months or more, and 46 patients (33.6%) for 1 year or longer. Patients treated only at the study site had a mean duration of antibiotic treatment of 283.1 days whereas patients who also received antibiotics from another institution had a mean duration of 380.2 days. This difference approached statistical significance (P = .054). LIMITATIONS: This study was limited to a single center. CONCLUSION: Expert guidelines recommend responsible use of antibiotics in acne in light of emerging resistance. We found that patients who eventually received isotretinoin had extended exposure to antibiotics, exceeding recommendations. Early recognition of antibiotic failure and the need for isotretinoin can curtail antibiotic use.
PMID: 26525749
ISSN: 1097-6787
CID: 1825782
BARRIERS TO PRIMARY ADHERENCE AT HOSPITAL DISCHARGE AMONG AN UNINSURED POPULATION IN NYC [Meeting Abstract]
Tang, Alice; Wells, Cassia; Milam, Emily; Janjigian, Michael
ISI:000358386900151
ISSN: 1525-1497
CID: 2330862
Raynaud Phenomenon
Milam, Emily C; Ramachandran, Sarika M; Franks, Andrew G Jr
PMID: 26650667
ISSN: 2168-6084
CID: 2041332
Treatment of Scarring Alopecia in Discoid Variant of Chronic Cutaneous Lupus Erythematosus With Tacrolimus Lotion, 0.3
Milam, Emily C; Ramachandran, Sarika; Franks, Andrew G Jr
IMPORTANCE: Discoid lupus erythematosus (DLE) is a chronic variant of cutaneous lupus erythematosus, an autoimmune inflammatory disorder of the skin. Lesions are often localized to the scalp and can result in permanent scarring, disfiguration, and irreversible alopecia. Although DLE usually responds to topical or intralesional corticosteroids and/or oral antimalarials, some DLE is resistant to these treatments or adverse effects limit their effectiveness. OBSERVATIONS: Three patients with treatment-refractory, biopsy-proved DLE were prescribed a novel, off-label preparation of tacrolimus lotion, 0.3%, in an alcohol base as an adjunct to oral antimalarial therapy. All 3 patients demonstrated improvement in lesion severity and hair regrowth with the use of this regimen after 3 months and continued improvement thereafter. We report a retrospective analysis of these 3 cases. CONCLUSIONS AND RELEVANCE: This report is, to our knowledge, the first mention of tacrolimus being used in a lotion formulation to treat DLE lesions, resulting in hair regrowth. Topical tacrolimus lotion, 0.3%, in an alcohol base may be a potential therapeutic option for patients with DLE that is refractory to first-line therapies and who risk late-stage disease with permanent scarring alopecia.
PMID: 26039539
ISSN: 2168-6084
CID: 1803072
19th Century Dermatologic Atlases in the Early Age of Photography
Milam, Emily C; Ramachandran, Sarika
PMID: 26352125
ISSN: 2168-6084
CID: 1772542